相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
Austin R. Dosch et al.
Oncotarget (2019)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation
Yang Fu et al.
CELL DEATH DISCOVERY (2018)
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
T. R. J. Evans et al.
ANNALS OF ONCOLOGY (2017)
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer
Christine M. Parseghian et al.
CLINICAL CANCER RESEARCH (2017)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
Aziz Zaanan et al.
BMC CANCER (2014)
The Inhibition of Src Family Kinase Suppresses Pancreatic Cancer Cell Proliferation, Migration, and Invasion
Dong Wook Je et al.
PANCREAS (2014)
Antioxidants decrease the apoptotic effect of 5-Fu in colon cancer by regulating Src-dependent caspase-7 phosphorylation
Y. Fu et al.
CELL DEATH & DISEASE (2014)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer
Daniel J. Renouf et al.
INVESTIGATIONAL NEW DRUGS (2012)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Current Status of Src Inhibitors in Solid Tumor Malignancies
Lauren N. Puls et al.
ONCOLOGIST (2011)
Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Jennifer P. Morton et al.
GASTROENTEROLOGY (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative Stress
Scott Kopetz et al.
CANCER RESEARCH (2009)
Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling
I. Ischenko et al.
ONCOGENE (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
Marwan Ghosn et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
